In vitro dilution models are used to simulate in vivo drug concentration-time profiles and thus to study the effects of various antibiotic concentrations on the bacteria investigated. The major disadvantage of these models is permanent dilution of the bacterial culture, which falsifies the resulting kill curves. Known equations, which usually correct bacterial loss by simple first-order kinetics, do not take into account special test conditions, such as variable elimination rate constants, exceptionally long periods of investigation, or formation of biofilms. In the present investigation, we examined the validity of these equations with regard to the test conditions mentioned. We simulated the concentration-time curves resulting from continuous infusion of 1,000 mg of meropenem with steady-state levels of 2.5, 5.0, and 7.5 g/ml in an in vitro dilution model. The resulting kill curves were compared with the kill curves obtained from incubation of bacteria in an undiluted system with meropenem at constant concentrations corresponding to the above-mentioned steady-state levels. Comparison of the matching kill curves showed that the common corrections, which do not consider the formation of biofilms in the compartments, partly overestimated the effect of bacterial dilution. We defined a factor, f, as an extension to the known equations which compensates for the effect of biofilms. Another extension was developed to allow the investigation of variable elimination rate constants. With the help of these extended mathematical corrections, we were able to fit the kill curves resulting from the in vitro dilution model exactly to the kill curves given by an undiluted system. Several in vitro kinetic models which simulate in vivo drug concentration-time profiles use continuous dilution to fit drug concentrations to the corresponding serum pharmacokinetics (4). The major disadvantage of these models is inevitable dilution of the bacterial culture, which falsifies the resulting kill curves. Several attempts have been made to compensate for this effect. (i) The antimicrobial activity of constant concentrations of antibiotics may be examined in a static system in which the bacterial culture is not diluted during the investigation (12). (ii) Dynamic in vitro models which do not allow bacteria to be washed out have been developed (1, 2). (iii) The loss of bacteria in an in vitro dilution model may be compensated for by mathematical correction.
In vitro dilution models are used to simulate in vivo drug concentration-time profiles and thus to study the effects of various antibiotic concentrations on the bacteria investigated. The major disadvantage of these models is permanent dilution of the bacterial culture, which falsifies the resulting kill curves. Known equations, which usually correct bacterial loss by simple first-order kinetics, do not take into account special test conditions, such as variable elimination rate constants, exceptionally long periods of investigation, or formation of biofilms. In the present investigation, we examined the validity of these equations with regard to the test conditions mentioned. We simulated the concentration-time curves resulting from continuous infusion of 1,000 mg of meropenem with steady-state levels of 2.5, 5.0, and 7.5 g/ml in an in vitro dilution model. The resulting kill curves were compared with the kill curves obtained from incubation of bacteria in an undiluted system with meropenem at constant concentrations corresponding to the above-mentioned steady-state levels. Comparison of the matching kill curves showed that the common corrections, which do not consider the formation of biofilms in the compartments, partly overestimated the effect of bacterial dilution. We defined a factor, f, as an extension to the known equations which compensates for the effect of biofilms. Another extension was developed to allow the investigation of variable elimination rate constants. With the help of these extended mathematical corrections, we were able to fit the kill curves resulting from the in vitro dilution model exactly to the kill curves given by an undiluted system. Several in vitro kinetic models which simulate in vivo drug concentration-time profiles use continuous dilution to fit drug concentrations to the corresponding serum pharmacokinetics (4) . The major disadvantage of these models is inevitable dilution of the bacterial culture, which falsifies the resulting kill curves. Several attempts have been made to compensate for this effect. (i) The antimicrobial activity of constant concentrations of antibiotics may be examined in a static system in which the bacterial culture is not diluted during the investigation (12) . (ii) Dynamic in vitro models which do not allow bacteria to be washed out have been developed (1, 2) . (iii) The loss of bacteria in an in vitro dilution model may be compensated for by mathematical correction.
In the present report, we have summarized the previously existing equations (5, 8, 11) and investigated their validity with regard to different test conditions by simulating continuous infusion of meropenem with steady-state levels of 2.5, 5.0, and 7.5 g/ml in an in vitro dilution model. The resulting time-kill curves were compared with the kill curves resulting from incubation of test bacteria with meropenem at constant concentrations of 2.5 to 7.5 g/ml in a static system (batch culture). We assumed that bacterial growth in the batch culture is not limited by the supply of nutrients as long as there is no regrowth beyond the initial inoculum. Under this prerequisite, all test conditions, except dilution, are identical in the corresponding experiments. Thus, the difference between the kill curves obtained under flowing and nonflowing conditions during the steady-state period gives the factor by which the kill curve obtained under flowing conditions has to be corrected for the bacterial loss due to dilution.
MATERIALS AND METHODS
Test bacteria. For the in vitro simulation, we used Pseudomonas aeruginosa III-3-1, which had originally been isolated from a human blood culture, and Escherichia coli K-12 strain W3110. The meropenem-MICs for the two strains were 0.25 and 0.06 g/ml, respectively. The strains were kept on China blue lactose agar (Merck, Darmstadt, Federal Republic of Germany [FRG] ). All studies were performed in Iso-sensitest broth (Oxoid, Wesel, FRG). Xanthomonas maltophilia IV-4-16 was used for the preparation of ␤-lactamase. The strain was a gift from Bayer AG, Leverkusen, FRG.
Antibiotics. Meropenem was kindly provided by Zeneca GmbH, Heidelberg, FRG. Stock solutions were freshly prepared in 5% K 2 HPO 4 . Cefoxitin was kindly provided by MSD Sharp & Dohme GmbH, Munich, FRG.
In vitro simulation. The data on a single 30-min infusion of 1,000 mg of meropenem were kindly provided by Zeneca. According to the rule given by Dost (3), the area under the concentration-time curve is in proportion to the total dose of an active substance and independent of the route of application as long as there is complete absorption and no first pass. From the pharmacokinetic data on the 30-min infusion, which has an area under the concentration-time curve of 62.60 g ⅐ h/ml, we calculated the concentration-time courses resulting from continuous infusions of 1,000 mg of meropenem with steady-state levels ranging from 2.5 to 7.5 g/ml. The theoretical serum concentrations of the simulated infusions are given in Fig. 1 ; measured concentration-time curves were accepted when the mean deviation from the expected values was less than 10%.
As a preparation for the experiments, the bacteria were grown overnight in Iso-sensitest broth at 37ЊC, diluted 100-fold, and preincubated in flask B (Fig. 2 ) for 1 h at 37ЊC. This provided an initial inoculum of approximately 10 7 CFU/ml. Kill kinetics under flowing conditions. Flasks A1 and A2 contained broth with different antibiotic concentrations, and flask R contained drug-free broth (Fig.  2) . During the experiments, medium was pumped from these compartments to flask B, which was kept at 37ЊC and contained bacteria in a constant volume (83 ml) of Iso-sensitest broth. We were able to simulate the different stages (i.e., loading dose, steady state, and elimination) of the continuous infusions investigated in compartment B by exchange of the supply flask (A1, A2, or R) and the flow rate ( Table 1 ). The flow rates employed, which ranged from 2 to 0.7 ml/min, were given by the product of the respective elimination rate constant, k e , and the volume of broth in compartment B. By the administration of loading doses (flask A1), the steady-state levels were reached within the first 30 min in all of the experiments.
Kill kinetics under nonflowing conditions (batch culture). In a second series of experiments, the antibiotic was directly added to test compartment B to give a concentration corresponding to the steady-state situation. These preparations were not diluted during the course of the experiment.
In all of the experiments, test samples were taken at t ϭ 0, 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 12, and 24 h. Bacterial colony counts in each sample were determined as follows. A 0.5-ml portion was removed from each sample and serially diluted in sterile saline. A 0.1-ml volume of each dilution was subcultured onto China blue lactose agar. Colony counts were determined after 18 h of incubation at 37ЊC and again after additional incubation for about 12 h at 37ЊC. The minimal detectable level was 100 CFU/ml. To eliminate the inhibiting effect of the antibiotic in the samples, two methods were used. (i) When the expected level was above 10,000 CFU/ml, the samples were diluted as described above. (ii) For levels below 10,000 CFU/ml, 0.05 ml of ␤-lactamase extract was added to 0.95 ml of each sample. The samples were then processed as usual. The resulting colony counts were multiplied by a factor of 1.05 to correct for the dilution due to the addition of ␤-lactamase. The ␤-lactamase allowed unimpaired bacterial growth from samples containing up to 25 g of meropenem per ml.
The difference between the measured log 10 CFU per milliliter and the log 10 CFU per milliliter of the initial inoculum was determined and plotted versus time of incubation.
Determination of MICs. MICs were determined with the broth dilution technique (9) in Iso-sensitest broth before and after each simulation. During the infusions investigated, no increase in the MIC occurred.
Determination of antibiotic concentrations. The concentrations of meropenem in the samples were determined by microbiological assay (6) in Isosensitest agar with E. coli II-1-32 as the test organism. Standards and samples (30 l) were placed in wells 6 mm in diameter. The meropenem assay was linear over a range of 0.3 to 2.5 g/ml; the coefficients of variation (standard deviation ⅐ 100/ mean diameter) were 5.94% at 0.3 g/ml, 4.36% at 0.6 g/ml, 4.50% at 1.25 g/ml, and 4.22% at 2.5 g/ml. The mean diameter of the zones of inhibition was 22.39 mm. Concentration-time curves were accepted when the mean difference between the measured and expected values was less than 10%.
Preparation of ␤-lactamase. For preparation of ␤-lactamase from X. maltophilia IV-4-16, we used the method given by Saino et al. (10) with slight modifications. In contrast to Saino et al., we used Iso-sensitest broth as the bacterial growth medium and cefoxitin at a final concentration of 60 g/ml as an inducer of ␤-lactamase production. After centrifugation, the cells were washed twice, resuspended in phosphate buffer at 0.05 times the original volume, and kept frozen overnight at Ϫ20ЊC. The next day, the suspension was warmed to 4ЊC, disrupted ultrasonically for 10 s in an ice bath, and centrifuged at 17,000 ϫ g for 20 min at 4ЊC. The supernatant was filtered through a membrane filter (cellulose nitrate, 0.22-m pore size) and kept frozen at Ϫ20ЊC.
The effect of ␤-lactamase was tested as follows. An overnight culture of P. aeruginosa III-3-1 was diluted in Iso-sensitest broth to a final inoculum concentration of approximately 400 CFU/ml. Samples of 0.5 ml were mixed either with 0.05 ml of ␤-lactamase or 0.05 ml of Iso-sensitest broth. Afterwards, 0.5 ml of meropenem diluted in Iso-sensitest broth was added to each sample to give final antibiotic concentrations ranging from 2.5 to 25 g/ml. The growth control was mixed with 0.05 ml of ␤-lactamase and 0.5 ml of Iso-sensitest broth. A 0.1-ml volume of each sample was immediately subcultured onto China blue lactose agar and incubated at 37ЊC for 18 h. The logarithm of the resulting number of CFU was plotted versus the antibiotic concentration in the sample (Fig. 3) .
Mathematical formulation. In 1986, Haag et al. (5) developed the following differential equations to describe changes in the number of cells (CFU per milliliter) in compartment B in the course of time. N(t) represents the number of CFU per milliliter in the free medium (liquid compartment) at a given time, t, and N B (t) stands for the number of cells in the biofilm (solid compartment) at the same time. dN(t)/dt and dN B (t)/dt represent the first derivatives of N(t) and N B (t), respectively. k w is the apparent bacterial growth rate constant (k w is the difference between the real growth rate constant and the rate constant of bacterial death; it is assumed that k w is the same under flowing and nonflowing conditions). k a is the rate constant for absorption of cells from the broth into the biofilm, k d is the rate constant for desorption of cells from the solid compartment into the free medium. k e is the elimination rate constant.
These equations have been developed under the assumptions that (i) k w is the same in broth and biofilm, (ii) k e , k a , and k d are constant over the complete course investigated, and (iii) N(t) is far below the maximum bacterial density under nonflowing conditions (N max ).
When k e equals zero (i.e., the culture in compartment B is not diluted), equation 1a is reduced to the following:
where dNЈ(t)/dt describes the change in the number of CFU per milliliter in an undiluted compartment in the course of time. 
where This equation, which compensates for the loss of bacteria according to simple first-order kinetics, has been known for a long time (8) .
In the second case, the desorption of biofilm cells into the liquid compartment surpasses the loss of bacteria due to dilution by far (i.e., k e Ӷ k d ). Under this condition, square terms of k e can be neglected. Taking into consideration the fact that A ϩ B ϭ N 0 , equations 4 and 5 resolve into the following:
Accordingly, NЈ(t) is given by the following:
Division of equations 8 and 9 results in the following:
Comparison of equations 7 and 10 reveals that the effect of biofilms upon the loss of bacteria should be compensated for by a factor, f, of between 0.5 and 1 in the exponent of the correction. With an increasing influence of the biofilm, this factor will come closer to 0.5. Thus, equations 7 and 10 may be combined to form the following general solution:
where 1 Ն f Ն 0.5. As mentioned before, equation 11 is valid only as long as k e is constant during the complete course of the investigation. If the serum pharmacokinetics examined show an additional phase of distribution and, accordingly, two different elimination rate constants for the ␣ and the ␤ phases, the equations have to be modified. Prerequisite to the following is that k e remain constant over defined periods ⌬t.
Under the assumption that there is no biofilm in the flasks, the starting point is given as equations 6a and b. By definition these equations are valid within periods ⌬t as follows:
⌬t1 and ⌬t2 represent adjoining periods ⌬t; the corresponding elimination rate constants are k e1 and k e2 . N1 and N2 stand for the numbers of CFU per milliliter at the end of the respective periods.
Combination of equations 12a and b results in the following:
With k e1 ϭ k e2 ϭ 0, the bacterial density in an undiluted compartment at the end of the second interval (N2Ј) can be expressed as follows:
Division of equations 13 and 14 results in the following:
Equation 15 can be transformed into the following general solution:
⌬t i and k ei represent any number of periods, ⌬t, with their corresponding elimination rate constants, k e . If there is a biofilm in the compartment, an identical transformation can be carried out with equations 8 and 9 as the starting point. This results in the following:
Combination of equations 16 and 17 gives the following general solution:
where 1 Ն f Ն 0.5. Unlike a bacterial growth curve, NЈ(t), as it is given by equation 18, does not reach the stationary phase. Correction of bacterial loss by unlimited first-order kinetics is therefore valid only as long as the cells are in the log phase [i.e., N(t) is much smaller than N max ). For cultures approaching the stationary phase, White et al. (11) developed the following equation, which comprises N max as the maximum bacterial density:
With bacterial densities beyond 10 8 KBE/ml, k w is not the same under flowing and nonflowing conditions. Equation 19, therefore, compensates not only for bacterial loss due to dilution but also for the different growth rates due to the limited supply of nutrients in the batch culture.
Nonetheless, equation 19 is valid only when there is no biofilm in the flasks and as long as k e is constant. Considering the influence of biofilms and a variable k e , equation 19 is transformed into the following:
where 1 Ն f Ն 0.5.
RESULTS

Evaluation of equation 18.
We recorded the kill curves resulting from the continuous infusions shown in Fig. 1 under flowing and nonflowing conditions with P. aeruginosa III-3-1 as the test organism. For each corresponding pair of curves, we calculated the correction factor, f, which was necessary in equation 18 to transform the kill curve obtained under flowing conditions during the steady-state period into the corresponding curve resulting from nonflowing conditions. As we expected the value of f to be dependent on the formation of adherent bacterial layers in the flasks, the existence of biofilms at the end of the investigation (i.e., after 24 h) was recorded. The data obtained are shown in Table 2 . The kill curve resulting from 2.5 g of meropenem per ml under nonflowing conditions showed a biphasic course (Fig. 4) . Separating the two phases and their corresponding correction factors, we found that the average values of f Ϯ the standard deviation were 0.87 Ϯ 0.07 for the first 2 h of the investigation and 0.62 Ϯ 0.10 from t ϭ 4 h to the end of the experiment. We suppose that the number of biofilm cells increases continuously from the start of the experiment, which is reflected by a continuous decrease in f. As we have described f by two average constants, this time dependency ought to be one of the factors influencing the observed standard deviation of f.
Evaluation of equation 20. To verify the validity of equation 20, we chose two different sets of test conditions. (i) The growth curves of E. coli K-12 strain W3110 uninfluenced by antibiotics were recorded under flowing and nonflowing conditions (Fig. 5 ). In agreement with White et al. (11), we found that correction for bacterial loss by an unlimited first-order correction gives false results when the observed bacterial density under nonflowing conditions exceeds 10 8 CFU/ml. For the curves depicted, we used an f value of 1 without regard to the formation of biofilms. The N max value of E. coli W3110 was determined to be 1.1 ⅐ 10 9 CFU/ml in the nonflowing system. (ii) On the basis of our investigations, we expected the unlimited correction also to yield false results when the experiments exceeded a certain period of time. We therefore continued some of our simulations (for test conditions, refer to Table 1 ) for more than 24 h with elimination rate constants ranging from 0.53 to 1.44 h Ϫ1 (data not shown). It became evident that the results given by equation 18 gradually deviated from the data obtained from an undiluted system when the time of incubation exceeded 12 h. Although the deviation was not significant until the experiment exceeded 24 h, provided there was no bacterial regrowth beyond 10 8 CFU/ml, we decided to use equation 20, which showed no or less deviation, from 12 h onward as a correction in all our investigations. The N max value of P. aeruginosa III-3-1 is 1.3 ⅐ 10 9 CFU/ml. As the bacterial densities at this time were usually rather low (less than 10 5 CFU/ml), the influence of correction factor f had to be considered; its values correspond to the data given in Table  2 .
DISCUSSION
In vitro models using first-order dilution represent a simple and generally applicable method to simulate serum pharmacokinetics (4). Their major disadvantage is continuous loss of bacteria by dilution, which interferes with the reduction in the number of CFU caused by the antimicrobial agent investigated. Neglecting this loss, as can be seen in some investigations (7), may be justified as long as the underlying concentration-time curve of the antibiotic is not altered. Thus, the comparison of the resulting kill kinetics is acceptable because the correction factor is a constant depending on the time of investigation and the resulting kill kinetics at least all bear the same mistake. The effect of bacterial dilution may also be neglected with antibiotics which reduce the number of CFU quickly almost to the limit of detection and do not allow bacterial regrowth during the period of investigation.
Correction for bacterial loss by dilution becomes necessary when kill curves resulting from the investigation of antibiotics with different elimination half-lives or strengths are to be compared. Corresponding investigations have used mainly simple first-order corrections (8) . These corrections correspond to equation 7 and may be accepted for most experiments, especially as long as the period of investigation does not exceed 8 h. According to our investigation, equation 19 should be used from 12 h onward. As the onset of formation and the activity of biofilms can only be roughly estimated by the data obtained from the in vitro model alone, the use of a constant correction factor, f ϭ 1, in both equations might be acceptable for the qualitative comparison of different antibiotics. With f ϭ 1, the resulting kill curves represent the worst case (i.e., the least reduction of bacterial density); thus, the effects of the antibi- 
